Puretech to present at the jefferies london healthcare conference

Boston--(business wire)--puretech health plc (nasdaq: prtc, lse: prtc) ("puretech" or the "company"), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today announced that daphne zohar, founder and chief executive officer, and julie krop, m.d.

PRTC Ratings Summary

PRTC Quant Ranking